Video del Professor Gerald Carr-White
In our latest Facebook Live video Dr Gerry Carr-White, Vice President and consultant cardiologist, shares his expertise on different cardiac devices, and what to be aware of during COVID-19 for those who have devices.
Dr Gerry Carr-White - Vice President of Cardiomyopathy UK, introduces some of the medication available for people affected by cardiomyopathy.
Dilated Cardiomyopathy (DCM). Dr Gerry Carr-White - Vice President of Cardiomyopathy UK, provides a detailed explanation of the condition.
Hypertrophic cardiomyopathy is a heart muscle disease that leads to an increased wall thickness surrounding the heart. Here to explain the condition in more detail is esteemed London-based consultant cardiologist, Professor Gerald Carr-White. If you are concerned about the current health of your heart, make sure you contact Professor Carr-White directly via his Top Doctors profile here: https://www.topdoctors.co.uk/doctor/gerald-carr-white ✔ Follow us on Instagram: https://bit.ly/3fSrqXb ✔ Follow us on Facebook: https://bit.ly/3t5kGsW ✔ Follow us on Twitter: https://bit.ly/39TidKh
By Dr Gerry Carr-White, Consultant Cardiologist, St Thomas’ Hospital, London. From his talk at the 2016 Cardiomyopathy UK national clinical conference
Dr Gerry Carr-White - Vice President of Cardiomyopathy UK, introduces some of the medication available for people affected by cardiomyopathy. Your questions: 38:55 - Can my beta-blocker restrict my ability to exercise? 39:48 - Can the timings of taking medication make a difference to the effect of the drugs? 40:38 - When will Dapagliflozin be available for heart failure patients and who will qualify? 41:20 - Is Mavacamten available on the NHS? 41:43 - I have DCM and I’ve been taking Ramipril for 10 years at a low dose. I have read that there’s a report saying long term use can contribute to developing lung cancer – what is your view on this? 42:05 - Myokardia and Cytokenetics both seem to be in late stage development drugs for HCM and DCM. Do you approximate time it may take before these get released to market if approved? And are there any other promising therapies in development? 42:34 - Are there any alternatives ACE Inhibitors to Ramipril? This is a recording of a live presentation at the Cardiomyopathy Conference 2020, hosted by Cardiomyopathy UK. We need your support to make up for lost income due to the impact of the Covid-19 pandemic on our fundraising, as we may lose as much as £180,000 or 20% of our income by the end of this year. Your donations help us to deliver events like the Cardiomyopathy Conference, reaching more people than ever before. If you can, please donate at https://www.cardiomyopathy.org/support-us-donate/regular-donations If any content infringes on copyright, we will remove it, just let us know. Please note, we do not own the presentations, only the recordings taken from our Conference. www.cardiomyopathy.org
This is a recording from the Cardiomyopathy UK 2022 Conference. Our conference events bring together leading cardiomyopathy clinicians to present and respond to audience questions. In this video, Professor Gerry Carr-White - Vice President of Cardiomyopathy UK, discusses Dilated Cardiomyopathy (DCM). Key Topics: 00:00:47 – What is dilated cardiomyopathy? 00:02:43 – What is the ‘Spectrum of DCM’? 00:03:25 – What is myocarditis? 00:04:00 – What is heart failure? 00:08:12 – What does a dilated cardiomyopathy look like on imaging tools? 00:09:10 – What is restrictive cardiomyopathy? 00:09:32 – What is arrhythmogenic cardiomyopathy? 00:12:07 – How many people have dilated cardiomyopathy? 00:12:38 – What causes dilated cardiomyopathy? 00:14:52 – How is dilated cardiomyopathy managed? 00:17:08 – What genes cause dilated cardiomyopathy? 00:22:38 – What is the non-pharmacological management of dilated cardiomyopathy? 00:25:30 – What are the pharmacological therapies for dilated cardiomyopathy? 00:35:00 – Can you stop taking medicines when you feel better? 00:36:18 – What are the mental health issues associated with cardiomyopathy? 00:38:08 – Sexual dysfunction and dilated cardiomyopathy 00:39:19 – Vaccines and dilated cardiomyopathy 00:40:18 – Equality and diversity in dilated cardiomyopathy 00:40:51 – Self-care and monitoring dilated cardiomyopathy 00:43:40 – Compliance with medicines for dilated cardiomyopathy 00:45:00 – Drugs to avoid in dilated cardiomyopathy 00:45:19 – Salt and fluid restriction in dilated cardiomyopathy 00:46:44 – Carers of those with dilated cardiomyopathy 00:47:09 – Palliative care in dilated cardiomyopathy 00:48:32 – Devices: defibrillators, pacemakers, LVAD and CRT implants 00:51:56 – COVID and dilated cardiomyopathy 00:52:20 – New therapies in dilated cardiomyopathy 00:53:12 – Coronary artery disease and dilated cardiomyopathy 00:54:47 – Lifestyle – smoking, weight, exercise, alcohol and diet 00:55:43 – Preparing for your appointments – what you should do and ask Audience questions: 00:58:08 – How different are outcomes depending on whether you attend a specialist or general cardiac centre? 01:00:00 – My ejection fraction has always been between 25-28%. Is there anything else I can do to increase my ejection fraction? 01:01:40 – Is short-term memory affected by medicines used to treat dilated cardiomyopathy? 01:03:15 – Is it necessary to have an MRI before having an ICD fitted? 01:05:20 – You mentioned two drugs that are less likely to cause sexual dysfunction – what were those? 01:06:44 – Will ICDs be MRI-compatible in the future? 01:08:20 – What is the strength of evidence for dapagliflozin in dilated cardiomyopathy? 01:10:11 – How much should me ejection fraction increase once I start the drug regime? Does exercise increase ejection fraction? 01:13:04 – Do the contrast agents used in some MRI or CT scans cause or worsen eczema? 01:14:01 – Should everyone with dilated cardiomyopathy be genetically tested? 01:16:00 – I suffer from extreme fatigue. Is there an other things I can do to reduce the fatigue? 01:17:46 – Can there be more than one cause of a dilated cardiomyopathy? 01:19:31 – How important is fluid restriction? How often should ejection fraction be monitored? 01:20:58 – Should you avoid high altitudes with dilated cardiomyopathy? 01:21:46 – Is there any new technology available to monitor ejection fraction at home? 01:23:33 – Is therapy for dilated cardiomyopathy with left bundle branch block (LBBB) any different? Access free information, find out about support groups and speak with cardiomyopathy Specialist Nurses at www.cardiomyopathy.org